EFDID: 70848EFD: View Filing

Issuer: Reven Pharmaceuticals, Inc. (0001556231) - D/A

Accession: 0000897069-14-000021 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001556231
  • Entity Name:
    Reven Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    FLORIDA
  • Year of Inc:
    Over 5 years ago
  • Address:
    4411 BEE RIDGE ROAD
    SUITE 285
    SARASOTA, FL 34233
  • Persons:
    Related Persons 3
    Peter B. Lange
    Executive OfficerDirector
    Brian Denomme
    Executive OfficerDirector
    Michael Handley
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    01/29/2014
  • First Sale Date:
    02/05/2013
  • Offering Amount:
    $2,000,000
  • Amount Sold:
    $1,833,055
  • Amount Remaining:
    $166,945
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt
  • Sales Clarification:
    The offering is completed.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Futures Investment Company 42402 None None SD, SC, UT, IL, NY, IN, GA, WI, AZ, KY, CA, MT, LA, VA, MI, OH, TX, WY, CO, IA, FL, NC, NE
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Reven Pharmaceuticals, Inc.Peter B. LangePeter B. LangePresident2014-01-28
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Jan. 29, 2014 70848: 0000897069-14-000021 Reven Pharmaceuticals, Inc.
Offer Amount: $2,000,000
Amount Sold: $1,833,055
Remaining: $166,945
D/A Jun. 05, 2013 70848: 0000897069-13-000270 Reven Pharmaceuticals, Inc.
Offer Amount: $2,000,000
Amount Sold: $526,025
Remaining: $1,473,975
D Mar. 08, 2013 70848: 0000897069-13-000189 Reven Pharmaceuticals, Inc.
Offer Amount: $1,000,000
Amount Sold: $22,500
Remaining: $977,500